Loss of Sirt2 increases and prolongs a caerulein-induced pancreatitis permissive phenotype and induces spontaneous oncogenic Kras mutations in mice

Sci Rep. 2018 Nov 7;8(1):16501. doi: 10.1038/s41598-018-34792-y.

Abstract

Mice lacking Sirt2 spontaneously develop tumors in multiple organs, as well as when expressed in combination with oncogenic KrasG12D, leading to pancreatic tumors. Here, we report that after caerulein-induced pancreatitis, Sirt2-deficient mice exhibited an increased inflammatory phenotype and delayed pancreatic tissue recovery. Seven days post injury, the pancreas of Sirt2-/- mice display active inflammation, whereas wild-type mice had mostly recovered. In addition, the pancreas from the Sirt2-/- mice exhibited extensive tissue fibrosis, which was still present at six weeks after exposure. The mice lacking Sirt2 also demonstrated an enhanced whole body pro-inflammatory phenotype that was most obvious with increasing age. Importantly, an accumulation of a cell population with spontaneous cancerous KrasG12D mutations was observed in the Sirt2-/- mice that is enhanced in the recovering pancreas after exposure to caerulein. Finally, transcriptome analysis of the pancreas of the Sirt2-/- mice exhibited a pro-inflammatory genomic signature. These results suggest that loss of Sirt2, as well as increased age, enhanced the immune response to pancreatic injury and induced an inflammatory phenotype permissive for the accumulation of cells carrying oncogenic Kras mutations.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Ceruletide / adverse effects*
  • Disease Models, Animal
  • Disease Susceptibility / immunology
  • Female
  • Genetic Predisposition to Disease
  • Immunohistochemistry
  • Male
  • Mice
  • Mice, Knockout
  • Mutation*
  • Pancreatitis / etiology*
  • Pancreatitis / metabolism*
  • Pancreatitis / pathology
  • Proto-Oncogene Proteins p21(ras) / genetics*
  • Regeneration
  • Sirtuin 2 / genetics*

Substances

  • KRAS protein, human
  • Ceruletide
  • Sirtuin 2
  • Proto-Oncogene Proteins p21(ras)